Control of the use of veterinary drugs and vaccines in aquaculture in the European Union.

Résumé fourni par la source

This paper attempts to explain as simply as possibl e the regulatory framework for veterinary medicines in the EU and in particular how this framework affects the availability of medicines in aquaculture. The ways in which these controls have been introduced, the reasons for them and how they have been developed, particularly in the last decade, are described. The requirements and costs of developing regulatory data for Marketing Authorisation for producers of pharmaceutical and immunological products are considered in the light of the limited potential for return of investment on their part.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.